The field of dermatology has witnessed remarkable progress in the prevention and treatment of skin diseases over the past ...

To the research team working to save him, KJ Muldoon was first known only as Patient Eta. But within months, KJ’s name — and ...

CRISPR, the gene-editing technology which won its creators the 2020 Nobel Prize for Chemistry, is most well-known for its ...

A recent study in the journal PNAS from the lab of Julie Overbaugh reveals a previously unknown antiviral function of a gene ...

CRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...

This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time.

The global pest control industry is steering towards a whopping $32.8 billion valuation by 2028, growing at a compound annual ...

The United States DNA polymerase market is projected to reach USD 246.9 million by 2035, supported by rising investments in ...

Now, it’s worth noting Stock Advisor's total average return is 991% — a market-crushing outperformance compared to 195% for ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...

The outlook for dementia care is changing fast. UC experts explain what that means for patients and families, and what it ...

Discover why Crispr Therapeutics AG is a strong buy with FDA-approved Casgevy, a promising pipeline, and major growth ...